increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by nobody – 2017-06-08 19:43 (2872 d 02:53 ago) – Posting: # 17467
Views: 15,057

❝ O.k., I see I need to add some more information. The idea behind this question is to develop an oral formulation with a less drug load than the reference product but with the same bioavailability in order to decrease non-systemic adverse events.


If you claim less AEs, you will have to proof it. In my opinion. So: Clinical trials ahead, I guess.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,691 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 22:37 CEST (Europe/Vienna)

Do not put your faith in what statistics say until you have carefully
considered what they do not say.    William W. Watt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5